HCAP Partners Invests in Real Diagnostics for Growth Expansion

September 23, 2025
HCAP Partners has announced its investment in Real Diagnostics, supporting Salt Creek Capital's acquisition and aiming to expand access to advanced diagnostic services.

HCAP Partners has announced its investment in Real Diagnostics, a clinical laboratory specializing in rapid and accurate testing, announced in a press release. This investment supports Salt Creek Capital's acquisition of RealDx and aims to expand access to high-quality diagnostic services.

RealDx provides diagnostic services across 17 states, offering test results within 24 hours and leveraging proprietary technology to enhance diagnostic accuracy. The company serves physician offices, specialty clinics, and skilled nursing facilities, distinguishing itself with its rapid and precise testing capabilities.

Cary Breese, the incoming CEO of RealDx, brings over 20 years of experience in healthcare and technology, having previously co-founded NowRx. With the support of Salt Creek Capital and HCAP Partners, RealDx is poised to expand its reach and continue delivering timely, accurate diagnostics to improve patient care.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more